Recent ADMA News
- ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law • Business Wire • 04/09/2026 10:07:00 AM
- ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop • PR Newswire (US) • 03/31/2026 10:07:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 11:05:42 AM
- ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research • GlobeNewswire Inc. • 03/27/2026 11:00:00 AM
- BFA Law Launches Investigation into ADMA Biologics after Short Seller Report -- Investors Notified to Contact BFA Law • Business Wire • 03/26/2026 06:34:00 PM
- ADMA Biologics rejects claims made in short-seller report • IH Market News • 03/25/2026 10:49:46 AM
- ADMA Biologics Addresses Misleading Short-Seller Report • GlobeNewswire Inc. • 03/25/2026 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2026 01:00:06 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/10/2026 01:00:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 02:00:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 12:05:40 PM
- ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative • GlobeNewswire Inc. • 03/02/2026 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 02:00:15 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/25/2026 10:16:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 09:11:12 PM
- ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/25/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 02:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 02:00:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 02:00:18 AM
- ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 • GlobeNewswire Inc. • 02/18/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 02:39:40 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/18/2026 02:02:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 02:00:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 02:00:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 02:00:19 AM
